Cancer Cause and Prevention Research in Oregon
Cancer Cause and Prevention Research (93.393) awarded $20.8 million to recipients in Oregon in 19 grants from fiscal 2021 to 2025, 0.6% of the program's national total. Oregon Health & Science University received the most, $10.4 million.
- Awarded in Oregon$20.8 million
- Awards19
- Share of the program0.6%
- Rank among states31st of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $2.9 million |
| FY 2022 | 8 | $3.6 million |
| FY 2023 | 11 | $4.0 million |
| FY 2024 | 11 | $5.1 million |
| FY 2025 | 9 | $5.2 million |
Recipients in Oregon
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Oregon Health & Science University | Colleges and universities | 9 | $10.4 million |
| University of Oregon | Colleges and universities | 3 | $3.2 million |
| Northwest Portland Area Indian Health Board | Tribal governments and organizations | 2 | $3.2 million |
| Collinge and Associates, Inc. | Small businesses | 2 | $2.4 million |
| Oregon State University | Colleges and universities | 2 | $952,162 |
| Ochin, Inc | Nonprofits | 1 | $649,293 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Oregon?
$20.8 million from fiscal 2021 to 2025, across 19 awards. Oregon ranks 31st of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Oregon?
The largest recipient is Oregon Health & Science University, with $10.4 million in 9 awards. Next are University of Oregon and Northwest Portland Area Indian Health Board.
Can organizations in Oregon apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Oregon
- Grants to States for Medicaid
- Highway Planning and Construction
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- National School Lunch Program
- Federal Transit Formula Grants
- Head Start
- Temporary Assistance for Needy Families
- Child Care and Development Block Grant